In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236
<p>(1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)</p>

In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236 (1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)

Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

The RMD Open podcast offers the latest insights in musculoskeletal disorders, rheumatism and connective tissue diseases. Each episode features in-depth interviews with authors and leading experts, discussing the latest research and treatments in the field.

RMD Open - rmdopen.bmj.com - is an esteemed international journal from the BMJ Group publishing original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation.

Stay ahead in your field by tuning into our expert discussions and accessing cutting-edge content.

Medicine

Health & Fitness

The RMD Open podcast offers the latest insights in musculoskeletal disorders, rheumatism and connective tissue diseases. Each episode features in-depth interviews with authors and leading experts, discussing the latest research and treatments in the field. RMD Open - rmdopen.bmj.com - is an esteemed international journal from the BMJ Group publishing original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Stay ahead in your field by tuning into our expert discussions and accessing cutting-edge content.

Share Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

Sign up to save your podcasts

Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

More shows like RMD Open Podcast

Medicine and Science from The BMJ

DTB Podcast

BJSM Podcast

Gut Podcast

Sharp Scratch

ADC Podcast

Thorax Podcast

STI Podcast

JNNP Podcast

Heart Podcast

JNIS Podcast

EBN Podcast

Practical Neurology Podcast

FG Podcast

Medical Humanities Podcast

Lupus Science and Medicine Podcast

ARD Podcast

BMJ Best Practice Podcast

IJGC Podcast